Tetrahydromagnolol Powder

About Tetrahydromagnolol PowderTetrahydromagnolol is a hydrogenated derivative of magnolol, one of the primary bioactive compounds found in magnolia bark. This compound acts as a potent CB2 cannabinoid receptor agonist and GPR55 antagonist, offering targeted support for physical comfort and a healthy inflammatory response, gastrointestinal wellness, and mood balance. Unlike magnolol, which requires unpredictable metabolic conversion, tetrahydromagnolol delivers immediate bioactivity with 19 times greater CB2 receptor affinity than its parent compound.
Our Tetrahydromagnolol Story
Traditional magnolia bark extracts rely on your body’s variable metabolism to convert magnolol into its more active metabolites, including tetrahydromagnolol. Most magnolol gets excreted unchanged because this conversion process is highly inconsistent between individuals and often inefficient. We saw that this metabolic bottleneck was preventing people from accessing the full potential of magnolia bark’s endocannabinoid effects.
We bypassed this biological variability entirely through controlled hydrogenation. We developed a precise process that transforms pure magnolol directly into tetrahydromagnolol using molecular hydrogen, removing the double bonds that limit CB2 receptor binding. This “pre-metabolized” approach provides consistent, predictable effects without relying on your individual enzymatic capacity. After years of development, we are the first vendor we’ve tested offering this rare compound, providing immediate access to magnolia bark’s most potent endocannabinoid metabolite.Benefits
Supports Physical Comfort: Tetrahydromagnolol acts as a potent CB2 cannabinoid receptor agonist with 19 times greater affinity than magnolol, providing targeted support for physical comfort throughout the body and particularly for nerve comfort support.
Supports Healthy Inflammatory Response: The compound’s dual action as a CB2 agonist and GPR55 antagonist helps modulate healthy inflammatory pathw…